Patents by Inventor Scott Eisenbeis

Scott Eisenbeis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination therapies for treating type 1 diabetes
    Patent number: 8758761
    Abstract: In accordance with the subject invention, combination therapies can be used to modulate a patient's immune response in order to prevent, delay and/or reverse type 1 diabetes.
    Type: Grant
    Filed: September 30, 2008
    Date of Patent: June 24, 2014
    Assignees: University of Florida Research Foundation, Inc., Genzyme Corporation
    Inventors: Mark A. Atkinson, Scott Eisenbeis, Donna Armentano, Abraham Scaria, Tracey Lodie
  • Method of treating autoimmune disease with mesenchymal stem cells
    Patent number: 8481022
    Abstract: Methods and compositions for treating an autoimmune disease, such as new onset type 1 diabetes (T1D) in a subject using autologous or allogeneic mesenchymal stem cells administered to the subject prior to autoimmune-induced complete depletion of insulin-producing pancreatic beta cells, e.g., within six months of new onset type 1 diabetes (T1D) diagnosis or prior to the onset of disease in a subject determined to be at high risk for T1D.
    Type: Grant
    Filed: July 28, 2011
    Date of Patent: July 9, 2013
    Assignee: Genzyme Corporation
    Inventors: Tracey Lodie, Michele Youd, Ross Tubo, Scott Eisenbeis
  • METHOD OF TREATING AUTOIMMUNE DISEASE WITH MESENCHYMAL STEM CELLS
    Publication number: 20120121611
    Abstract: Methods and compositions for treating an autoimmune disease, such as new onset type 1 diabetes (T1D) in a subject using autologous or allogeneic mesenchymal stem cells administered to the subject prior to autoimmune-induced complete depletion of insulin-producing pancreatic beta cells, e.g., within six months of new onset type 1 diabetes (T1D) diagnosis or prior to the onset of disease in a subject determined to be at high risk for T1D.
    Type: Application
    Filed: July 28, 2011
    Publication date: May 17, 2012
    Inventors: Tracey LODIE, Michele Youd, Ross Tubo, Scott Eisenbeis
  • Combination Therapies for Treating Type 1 Diabetes
    Publication number: 20100322894
    Abstract: In accordance with the subject invention, combination therapies can be used to modulate a patient's immune response in order to prevent, delay and/or reverse type 1 diabetes.
    Type: Application
    Filed: September 30, 2008
    Publication date: December 23, 2010
    Inventors: Mark A Atkinson, Scott Eisenbeis, Donna Armentano, Abraham Scaria, Tracey Lodie
  • METHOD OF TREATING AUTOIMMUNE DISEASE WITH MESENCHYMAL STEM CELLS
    Publication number: 20090324609
    Abstract: Methods and compositions for treating an autoimmune disease, such as new onset type 1 diabetes (T1D) in a subject using autologous or allogeneic mesenchymal stem cells administered to the subject prior to autoimmune-induced complete depletion of insulin-producing pancreatic beta cells, e.g., within six months of new onset type 1 diabetes (T1D) diagnosis or prior to the onset of disease in a subject determined to be at high risk for T1D.
    Type: Application
    Filed: August 8, 2008
    Publication date: December 31, 2009
    Applicant: Genzyme Corporation
    Inventors: Tracey Lodie, Michele Youd, Ross Tubo, Scott Eisenbeis